Blog cover Polymorphism in Pharmaceutical Intermediates guide, solid form management, ritonavir crystal case, ICH Q6A rule and polymorph risk check on supplier COA for pharma purchasers
blog, Buyer Resources

Polymorphism in Pharmaceutical Intermediates: Why Solid Form Control Matters

This guide explains what polymorphism means for intermediate buyers, how ICH Q6A Decision Tree #4 governs solid form control, which COA red flags signal polymorph gaps, and three questions every buyer should ask their supplier before committing to a purchase.